CL
JNCE

CSS LLC’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

CSS LLC’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,000
Closed -$46.3K – 815
2023
Q1 		$46.3K Buy
+25,000
New +$46.3K ﹤0.01% 479
2020
Q4 		– Sell
-29,000
Closed -$237K – 731
2020
Q3 		$237K Buy
+29,000
New +$237K 0.01% 337